A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Cholangiocarcinoma|Urothelial Cancer|Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors|Primary CNS Tumors|Breast Cancer|Gastric Cancer
Interventions: DRUG: Futibatinib
Sponsor: Taiho Oncology, Inc.